Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2014 Feb 18;23(5):515–525. doi: 10.1002/pds.3595

Table 3.

Sources of variance in heparin dose for maintenance hemodialysis in older U.S. patients.

Model Patient level R-squared:
% variance at patient level explained by the model (95% confidence interval)
Facility level R-squared:
% variance at facility level explained by the model (95% confidence interval)
Adjusted for patient characteristics only1 23% (22%–25%) 21% (18%–24%)
Adjusted for patient + facility characteristics2 25% (24%–27%) 27% (24%–31%)
1

Patient characteristics included age, sex, race, ethnicity, comorbidities, weight, blood pressure, hemoglobin, platelet count, albumin, vascular access, length of session, reuse status of the dialyzer, and years on dialysis.

2

Facility characteristics included number of outpatient hemodialysis patients, by quartile, urban/rural status, and census division.